NCT06611345 2024-10-26A Study of Tumor-Treating Fields in Combination With Durvalumab and Gemcitabine/Cisplatin in Biliary Tract CancersJiangsu Healthy Life Innovation Medical Technology Co., LtdPhase NA Recruiting60 enrolled